Liang Shan

Medicine & Life Sciences

1. HIV-1 100%
2. T-Lymphocytes 34%
3. Inflammasomes 33%
4. Human immunodeficiency virus 1 p16 protease 31%
5. HIV 26%
6. HIV Infections 24%
7. Baculoviridae 23%
8. Human Herpesvirus 4 22%
9. Natural Killer Cells 20%
10. Proviruses 20%
11. Caspase Activation and Recruitment Domain 18%
12. Pyroptosis 17%
13. Viruses 16%
14. Reverse Transcriptase Inhibitors 12%
15. Hematopoietic Stem Cells 12%
16. Peptide Hydrolases 12%
17. Highly Active Antiretroviral Therapy 12%
18. EBV-encoded nuclear antigen 1 11%
19. Human Development 11%
20. Proteins 10%
21. Mucous Membrane 10%
22. Neutrophils 10%
23. Virus Latency 10%
24. Enterovirus 10%
25. Lymphocytes 10%
26. Veillonella 10%
27. Antiviral Agents 9%
28. HIV Protease Inhibitors 9%
29. Infections 9%
30. Cyclonic Storms 9%
31. Disulfiram 9%
32. Rotavirus Infections 9%
33. Genes 8%
34. Antibodies 8%
35. Protein Array Analysis 8%
36. Food Supply 8%
37. Cytokines 8%
38. Cytoprotection 7%
39. Protease Inhibitors 7%
40. Histone Deacetylase Inhibitors 7%
41. Rotavirus 7%
42. Nasopharyngeal Carcinoma 7%
43. Microbiota 7%
44. RNA 7%
45. Transgenes 7%
46. Macrophages 7%
47. Cytotoxic T-Lymphocytes 7%
48. Immunotherapy 7%
49. Pharmaceutical Preparations 7%
50. Life Cycle Stages 7%